Patent Reports Sample Clauses

Patent Reports. At the end of each Collaboration Year during the term of this Agreement, each party shall provide the Patent Committee with a report, in form and substance to be determined by the Patent Committee, identifying (i) patent applications comprising any Evogene Patent Rights, Evogene Discovery Round Patent Rights or Evogene G2P Round Patent Rights that were filed during the preceding year and the prosecution status of all previously-filed patent applications comprising Evogene Patent Rights, Evogene Discovery Round Patent Rights or Evogene G2P Round Patent Rights, and (ii) (A) for the first such report after the date that any Excluded Collaboration Hit or Excluded PlaNet Xxxx Xxxxx arises, patent applications comprising any Monsanto Improvement Patent Rights covering such Excluded Collaboration Hit or Excluded PlaNet Xxxx Xxxxx and the prosecution status thereof, and (B) for each subsequent year after an Excluded Collaboration Hit or Excluded PlaNet Xxxx Xxxxx arises, all patent applications comprising any Monsanto Improvement Patent Rights covering such Excluded Collaboration Hit or Excluded PlaNet Xxxx Xxxxx that were filed during the preceding year and the prosecution status of all previously-filed patent applications comprising any Monsanto Improvement Patent Rights covering such Excluded Collaboration Hit or Excluded PlaNet Xxxx Xxxxx.
AutoNDA by SimpleDocs
Patent Reports. All DOTC Base Agreements shall require the use of DD Form 882, Report of Inventions and Subcontracts, to file an invention report for every OTIA. Negative reports are also required. The NAC Member shall provide the CMF, with an Annual Invention Report at the close of each performance year of each OTIA and at the end of the term of each OTIA.
Patent Reports. The Consortium or Consortium Members shall file Invention (Patent) Reports as of the close of the performance year and at the end of each project award for this Agreement or more frequently if a statutory bar will occur before the next annual or final project report. Annual reports are due sixty (60) calendar days after the expiration of the final performance period. The Research Project Awardee shall use DD Form 882, Report of Inventions and Subawards (or forms appropriate to non DoD agencies), to file an invention report. Such reports are required whether or not a Subject Invention was made. The patent recipient Consortium Member(s) shall submit the original and one copy to the AO, through the CM, and one copy to the technology scientist or engineer. Authorization and Consent. The Government authorizes and consents under 28 U.S.C. 1498 to all use and manufacture of any invention described in and covered by a United States patent in the performance of this Agreement or any subaward at any tier. Final Payment. Final payment cannot be made nor can the Agreement be closed-out until the patent recipient, Consortium or Consortium Members deliver to the Government all disclosures of Subject Inventions required by this Agreement, an acceptable final report pursuant to the article entitled “Reports,” and all confirmatory instruments.
Patent Reports. The Consortium or Consortium Members shall file Invention (Patent) Reports as of the close of the performance year and at the end of each project award for this Agreement or more frequently if a statutory bar will occur before the next annual or final project report. Annual reports are due sixty (60) calendar days after the expiration of the final performance period. The Researc Project Awardee shall use DD Form 882, Report of Inventions and Subawards (or forms appropriate to non DoD agencies), to file an invention report. Such reports are required whether or not a Subject Invention was made. The patent recipient Consortium Member(s) shall submit the original and one copy to the AO, through the CM, and one copy to the technology scientist or engineer.
Patent Reports. Seller shall file Invention (Patent) Reports at the close of the performance year and at the end of the term of this Contract. Annual reports are due thirty (30) calendar days after the expiration of the final performance period. Seller shall use the DD Form 882, Report of Inventions and Subcontracts, to file an invention report. Negative reports are also required. Seller shall contact Xxxxx’s Authorized Procurement Representative to obtain the name and address of the government representative for the required reports. Seller shall also submit one copy to Xxxxx’s Authorized Procurement Representative.
Patent Reports. At the end of each calendar year during the term of this Agreement, the Patent Committee shall prepare a report, in form and substance to be determined by the Patent Committee, identifying the patent applications comprising Joint IP, Biotectix Technology, or Acutus Technology that were filed during the preceding calendar year and the prosecution status of all previously-filed patent applications comprising Joint IP, Biotectix Technology, or Acutus Technology.
Patent Reports. The recipient shall utilize DD Form 882, Report of Inventions and Subcontracts, for submission of interim and final invention reports. The DD Form 882 and all invention disclosures shall be submitted to the Administrative Agreements Officer for proper disposition and forwarding to the Agreements Officer.
AutoNDA by SimpleDocs
Patent Reports. Property Reports: (Other reporting as may be dictated by your prime) Reports: All reports to Sponsor are due within 60 days after expiration or termination of the Agreement other than for material breach by Sponsor, extendable for 90 days by Principal Investigator with consent by the Sponsor Technical Representative, which the Sponsor Technical Representative may not unreasonably withhold.

Related to Patent Reports

  • Licensed Patents Licensee shall be responsible for all further patent prosecution with respect to the Licensed Patents and Licensed Technologies set out in Exhibit “A”. Licensee may select the patent agent for the prosecution of the Licensed Patents, subject to the approval of Licensor as the patent owner, which approval will not be unreasonably withheld. Licensee shall provide Licensor with copies of all relevant documentation related to the filing and prosecution of the Licensed Patents so that Licensor may be informed and apprised of and meaningfully consulted as to the continuing prosecution. Licensor shall keep all such documentation confidential. In the event the Licensee does not agree that any given patent application or patent should be filed, prosecuted or maintained (hereinafter referred to as a “Refused Licensed Patent”) in a particular jurisdiction(s) Licensee shall indicate such disagreement in writing (hereinafter “Refusal Notice”) and upon Licensor’s receipt of such Refusal Notice Licensor shall have the right unilaterally to make, prosecute and maintain such Refused Licensed * Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission Patent in such jurisdiction(s) in the name of its owners, at Licensor’s expense, and Licensee shall not have any rights or obligations to such Refused Licensed Patent in such jurisdiction(s); provided, however, that Licensee shall retain all of its ownership rights in any Refused Licensed Patent that is a Co-Owned Technology. In such case Licensor shall provide Licensee with copies of all relevant documentation related to the filing and prosecution of the Refused Licensed Patents so that Licensee may be informed and apprised of and be meaningfully consulted with as to the continuing prosecution. Licensor shall have no obligation to continue prosecution or maintenance of any Refused Licensed Patent and may abandon same without any prior notice or any obligation to Licensee. Both Licensee and Licensor shall make best efforts to respond promptly to any request from the other Party for input or assistance with respect to matters pertaining to the Licensed Patents. Licensee shall use reasonable efforts to amend any patent application to include claims reasonably requested by the other Party and required to protect the Licensed Technology. In addition to Licensee’s obligations pursuant to section 4.1 above, Licensee shall be solely responsible for all patent and legal costs relating to the Licensed Patents and Licensed Technology (excluding Refused Licensed Patents) from the Effective Date onward, including all costs relating to the transfer of the Licensed Patents to the new patent agents selected by Licensee and approved by Licensor. For any patent and legal costs relating to the Licensed Patents and Licensed Technology (excluding Refused Licensed Patents) paid by Licensor after the Effective Date (including, without limitation, those expenses related to patentability assessments and drafting, filing, prosecution, maintenance, and taxes (the “Patent Costs”)), Licensee shall promptly reimburse Licensor for such Patent Costs upon receipt of an invoice from Licensor for such expenses. For any work in progress with respect to the Licensed Patents for which the Patent Costs have not already been paid by Licensor to its patent firm prior to the transfer of the Licensed Patents to Licensee’s patent agent, Licensor will direct its patent firm to copy Licensee on all such invoices from said patent firm and Licensee will promptly pay said invoices directly to Licensor’s patent firm.

Time is Money Join Law Insider Premium to draft better contracts faster.